公开(公告)号：US20170296574A1

公开(公告)日：2017-10-19

申请号：US15635517

申请日：2017-06-28

Applicant: CytoSorbents Corporation

Inventor： Phillip P. Chan ,  Wei-Tai Young ,  Vincent J. Capponi ,  Thomas D. Golobish ,  Humayra Begum Ali

IPC: A61K31/745 ,  A61K9/16 ,  A61K9/50 ,  C08J9/26 ,  B01J20/26 ,  B01J20/30 ,  A61K9/00 ,  B01J20/28 ,  C08F212/36

CPC classification number: A61K31/745 ,  A61K9/0053 ,  A61K9/16 ,  A61K9/50 ,  A61K31/74 ,  A61K31/75 ,  A61K47/58 ,  B01J20/261 ,  B01J20/28004 ,  B01J20/28073 ,  B01J20/28076 ,  B01J20/3064 ,  C08F212/36 ,  C08J9/26 ,  C08J2201/0444 ,  C08J2207/10 ,  C08J2325/02 ,  Y02A50/406 ,  Y02A50/411

Abstract: The present invention concerns methods of treating systemic, regional, or local inflammation from a patient suffering or at risk of inflammation comprising administration of a therapeutically effective dose of a sorbent that sorbs an inflammatory mediator in said patient. In some preferred embodiments, the sorbent is a biocompatible organic polymer.